1,325 research outputs found
Semi-Analytical Calculation of Pore-Related Parameters of Wire/Woven Screens
Wire/woven screens have a wide range of applications, from being used as simple mechanical screening device to nanoscreen wicking with nanofluids. The vast number of applications makes important to study these screens with high accuracy, to reduce errors in characterisation and performance predictions. Previous works to date focused either on the study of these screens as a two-dimensional surface (e.g. in ventilation openings as insect-proof screens) or as three-dimensional structures under important assumptions (symmetric mesh, thickness of two times their diameter, linear evolution of the pore area along the thickness). These
incomplete modellings introduce errors in applications such as the estimation of permeability of the porous media (two-dimensional porosity is identical for two meshes with the same projected area of pore but different thickness) or computational simulations of ventilation in buildings/greenhouses, where these parameters are imposed as boundary condition. The present investigation shows a method to calculate three-dimensional pore related structural properties semi-analytically for the first time and for any plain square mesh. We found that when sweeping the mesh with a plane parallel to it there are up to six different zones or stretches which can be
integrated by a piece-wise approach (here named Discretisation Method). Results demonstrated high accuracy in the calculation of three-dimensional porosity and constriction factor (a parameter that is calculated by integration over the pore volume). Due to the mathematical complexity in the method, a software (AeroScreen v1.0) is available to obtain pore-related structural parameters from diameters, separations and thickness of the screen
Recommended from our members
Analysis of turbulent air flow characteristics due to the presence of a 13 × 30 threads·cm^−2 insect proof screen on the side windows of a Mediterranean greenhouse
Insect-proof screens are a frequent passive method to restrict the entrance of insects into greenhouses. However, the installation of these screens also has a negative effect on natural ventilation, which is reflected in the turbulence and velocity of the airflow inside the greenhouse. The turbulent characteristics of airflow through an insect-proof screen installed in the greenhouse windows have not been studied thoroughly in the literature. The present work focuses on the use of two simultaneous 3D sonic anemometers to study the impact of the use of a 13 × 30 threads·cm−2 insect-proof screen on the turbulence properties of the micro and microscale airflow turbulence. Four tests have been carried out in windward-oriented side windows of a Mediterranean greenhouse. Results demonstrate that the approach of using two simultaneous 3D sonic anemometers for the first time allows one to observe that the effect is different for the three components of the velocity vector field, and there is a strong connection between the simultaneous conditions inside and outside of the greenhouse. Useful information and data on the effect of using a 13 × 30 threads·cm^−2 insect-proof screen are also provided. To give details on the impact of screens in the turbulent properties of ventilation is essential for any commercial distribution, as well as providing important data in the design and development of more efficient insect-proof screens
Recommended from our members
Improvements in the characterization of permeability and inertial factor of insect-proof screens through pressure drop coefficients
Permeability and inertial factor are the most relevant variables in the Forchheimer equation. They are important to estimate pressure drop when a fluid flow is passing through a porous media. However, in the insect-proof screens field, the existing models to date are still providing a poor predictive accuracy, in part due to they are based on 2D porosity of screens. This work provides novel models for permeability and inertial factor, which are developed from experimental data of insect-proof screens in a wind tunnel and the analytical estimation of 3D porosity. Instead of fitting models directly on observed training data values of permeability and inertial factor, we propose to focus the modelling efforts on finding models dependent on the 3D porosity through the constants in the pressure drop of Forchheimer equation. Since two screens can have the same 2D porosity but different 3D porosity, this makes also models more reliable. The combination of all these aspects has led to parametric models that overcome by far predictions by previous models in the literature
Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis
BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London
Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world
Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.
Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.
Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.
Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis.
Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
OBJECTIVE: To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the Myasthenia Gravis Foundation of America (MGFA) post-intervention status of minimal manifestations (MM), we assessed patients' status throughout REGAIN (Safety and Efficacy of Eculizumab in AChR+ Refractory Generalized Myasthenia Gravis) and its open-label extension. METHODS: Patients who completed the REGAIN randomized controlled trial and continued into the open-label extension were included in this tertiary endpoint analysis. Patients were assessed for the MGFA post-intervention status of improved, unchanged, worse, MM, and pharmacologic remission at defined time points during REGAIN and through week 130 of the open-label study. RESULTS: A total of 117 patients completed REGAIN and continued into the open-label study (eculizumab/eculizumab: 56; placebo/eculizumab: 61). At week 26 of REGAIN, more eculizumab-treated patients than placebo-treated patients achieved a status of improved (60.7% vs 41.7%) or MM (25.0% vs 13.3%; common OR: 2.3; 95% CI: 1.1-4.5). After 130 weeks of eculizumab treatment, 88.0% of patients achieved improved status and 57.3% of patients achieved MM status. The safety profile of eculizumab was consistent with its known profile and no new safety signals were detected. CONCLUSION: Eculizumab led to rapid and sustained achievement of MM in patients with AChR+ refractory gMG. These findings support the use of eculizumab in this previously difficult-to-treat patient population. CLINICALTRIALSGOV IDENTIFIER: REGAIN, NCT01997229; REGAIN open-label extension, NCT02301624. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that, after 26 weeks of eculizumab treatment, 25.0% of adults with AChR+ refractory gMG achieved MM, compared with 13.3% who received placebo
Robust estimation of bacterial cell count from optical density
Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data
- …